Product Monograph - Pradaxa® Reversal Agent
Overview • PRAXBIND is an immediate and specific reversal agent for PRADAXA • PRAXBIND is indicated in patients treated with PRADAXA when reversal of the anticoagulant effects of
Download Product Monograph - Pradaxa® Reversal Agent
Information
Domain:
Source:
Link to this page:
Documents from same domain
DOSING & MANAGEMENT GUIDE - Praxbind
www.praxbind.comSafety first—Immediate reversal available nationwide1,2 DOSING & MANAGEMENT GUIDE Please see Important Safety Information …
Related documents
NOAC GUIDELINES - NSW Health
www.cec.health.nsw.gov.aunoac guidelines non-vitamin k antagonist oral anticoagulant updated july 2017
Reversing the New Anticoagulants - UCSF CME
www.ucsfcme.com11/6/2013 2 Roadmap for today • Characteristics of novel anticoagulants • Approach to the bleeding patient • Specific reversal agents • UCSF guidelines Scope of Problem • Prevalence atrial fibrillation • 3.03 million in 2005 • 7.56 million by 2050 • VTE = 900K/yr in US • 1-2% of adults take warfarin Warfarin 1920s –Outbreak hemorrhagic disease in cattle in
Anticoagulation in acute pulmonary embolism
www.uky.eduAnticoagulation in acute pulmonary embolism
DOAC At-a-Glance Reference updated: August 2018
www.mghpcs.orgerythromycin) avoided . P. reduction. Halflife: 5-9h . Tmax: 2-4h. NVAF . CrCl>50 mL/min 20mg daily with food AVOID concomitant P-gp and strong CYP3A4 inhibitors (ketoconazole,